Literature DB >> 16879819

Nutritional antioxidants and age-related cataract and maculopathy.

Chung-Jung Chiu1, Allen Taylor.   

Abstract

Loss of vision is the second greatest, next to death, fear among the elderly. Age-related cataract (ARC) and maculopathy (ARM) are two major causes of blindness worldwide. There are several important reasons to study relationships between risk for ARC/ARM and nutrition: (1) because it is likely that the same nutritional practices that are associated with prolonged eye function will also be associated with delayed age-related compromises to other organs, and perhaps, aging in general, (2) surgical resources are insufficient to provide economic and safe surgeries for cataract and do not provide a cure for ARM, and (3) there will be considerable financial savings and improvements in quality of life if health rather than old age is extended, particularly given the rapidly growing elderly segment of our population. It is clear that oxidative stress is associated with compromises to the lens and retina. Recent literature indicates that antioxidants may ameliorate the risk for ARC and ARM. Given the association between oxidative damage and age-related eye debilities, it is not surprising that over 70 studies have attempted to relate antioxidant intake to risk for ARC and ARM. This article will review epidemiological literature about ARC and ARM with emphasis on roles for vitamins C and E and carotenoids. Since glycation and glycoxidation are major molecular insults which involve an oxidative stress component, we also review new literature that relates dietary carbohydrate intake to risk for ARC and ARM. To evaluate dietary effects as a whole, several studies have tried to relate dietary patterns to risk for ARC. We will also give some attention to this emerging research. While data from the observational studies generally support a protective role for antioxidants in foods or supplements, results from intervention trials are less encouraging with respect to limiting risk for ARC/ARM prevalence or progress through antioxidant supplementations, or maintaining higher levels of antioxidants either in diet or blood. Without more information it is difficult to parse these results. It would be worthwhile to determine why the various types of studies are not yielding similar results. However, there are many common insults and mechanistic compromises that are associated with aging, and proper nutrition early in life may address some of these compromises and provide for extended youthful function later in life. Indeed, proper nutrition, possibly including use of antioxidant supplements for the nutritionally impoverished, along with healthy life styles may provide the least costly and most practical means to delay ARC and ARM. Further studies should be devoted to identifying the most effective strategy to prevent or delay the development and progress of ARC/ARM. The efforts should include identifying the right nutrient(s), defining useful levels of the nutrient(s), and determining the age when the supplementation should begin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879819     DOI: 10.1016/j.exer.2006.05.015

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  55 in total

1.  Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.

Authors:  Qingning Bian; Shasha Gao; Jilin Zhou; Jian Qin; Allen Taylor; Elizabeth J Johnson; Guangwen Tang; Janet R Sparrow; Dennis Gierhart; Fu Shang
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

Review 2.  [Vitamins for the eyes? Risks and opportunities for physician and patient].

Authors:  R Grossklaus; K J Henning
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

3.  Vitamin E and age-related macular degeneration in a randomized trial of women.

Authors:  William G Christen; Robert J Glynn; Emily Y Chew; Julie E Buring
Journal:  Ophthalmology       Date:  2010-02-13       Impact factor: 12.079

4.  Nutrient patterns and risk of cataract: a case-control study.

Authors:  Fatemeh Sedaghat; Matin Ghanavati; Parisa Nezhad Hajian; Sara Hajishirazi; Mehdi Ehteshami; Bahram Rashidkhani
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

5.  Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration.

Authors:  Chung-Jung Chiu; Yvette P Conley; Michael B Gorin; Gary Gensler; Chao-Qiang Lai; Fu Shang; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

Review 6.  Vitamin C and the Lens: New Insights into Delaying the Onset of Cataract.

Authors:  Julie C Lim; Mariana Caballero Arredondo; Andrea J Braakhuis; Paul J Donaldson
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

Review 7.  Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection.

Authors:  Palsamy Periyasamy; Toshimichi Shinohara
Journal:  Prog Retin Eye Res       Date:  2017-08-31       Impact factor: 21.198

8.  Selenium and mercury in the Brazilian Amazon: opposing influences on age-related cataracts.

Authors:  Mélanie Lemire; Myriam Fillion; Benoît Frenette; Annie Mayer; Aline Philibert; Carlos José Sousa Passos; Jean Rémy Davée Guimarães; Fernando Júnior Barbosa; Donna Mergler
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

9.  Age-related cataracts: homocysteine coupled endoplasmic reticulum stress and suppression of Nrf2-dependent antioxidant protection.

Authors:  Rajan Elanchezhian; Periyasamy Palsamy; Christian J Madson; David W Lynch; Toshimichi Shinohara
Journal:  Chem Biol Interact       Date:  2012-09-01       Impact factor: 5.192

10.  Preventive effect of onion juice on selenite-induced experimental cataract.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Somayeh Bonyadi; Mohammad Reza Rashidi; Mehran Mesgari; Nadereh Rashtchizadeh; Hassan Argani
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.